Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.00049293460400922 0.000164311534669818 0.000821557673348739
Stock impact report

Biotech Analysis Central Pharma News: Regeneron's Reversal Of Fortune, Bristol-Myers Squibb's FDA Win, Novo Nordisk's Acquisition [Seeking Alpha]

Bristol-Myers Squibb Company (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
Company Research Source: Seeking Alpha
Summary Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Regeneron Receives Favorable FDA Approval Outcome After A Bump In The Road News: Recently, Regeneron Pharmaceuticals ( REGN ) announced that the FDA had approved its supplemental Biologics License Application (sBLA) for EYLEA in treating patients with wet age-related macular degeneration (Wet-AMD). The reason for this supplemental application was so that Regeneron could receive approval for its 12-week dosing schedule. This means giving doses every 12 weeks, and several injections after as needed. Before approval, EYLEA was given by intravitreal injection every 4 weeks (monthly) for the first 12 weeks (3 months). Which was then followed by an injection once every 8 weeks (2 months). The FDA approval was based on data from two Phase 3 studies. These studies were VIEW 1 and VIEW 2 respectively. Both of these studies showe Show less Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BMY alerts
Opt-in for
BMY alerts

from News Quantified
Opt-in for
BMY alerts

from News Quantified